These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1110 related items for PubMed ID: 15337695

  • 1. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ, Dowling TC, Meadows D, Ayala T, Marshall J, Minshall S, Greenberg N, Thattassery E, Fisher ML, Rao K, Gottlieb SS.
    Circulation; 2004 Sep 21; 110(12):1620-5. PubMed ID: 15337695
    [Abstract] [Full Text] [Related]

  • 2. Effect of nesiritide on renal function in patients admitted for decompensated heart failure.
    Arora S, Clarke K, Srinivasan V, Gradman A.
    QJM; 2007 Nov 21; 100(11):699-706. PubMed ID: 17971392
    [Abstract] [Full Text] [Related]

  • 3. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S, Warfield KT, Wood CM, Miller WL.
    Am J Cardiol; 2006 Dec 15; 98(12):1627-30. PubMed ID: 17145223
    [Abstract] [Full Text] [Related]

  • 4. Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritide.
    Miller WL, Kurien S, Warfield KT, Wood CM, Jaffe AS.
    Int J Cardiol; 2008 May 23; 126(2):234-9. PubMed ID: 17482692
    [Abstract] [Full Text] [Related]

  • 5. The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment.
    Dittrich HC, Gupta DK, Hack TC, Dowling T, Callahan J, Thomson S.
    J Card Fail; 2007 Oct 23; 13(8):609-17. PubMed ID: 17923351
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of nesiritide in pediatric heart failure.
    Jefferies JL, Price JF, Denfield SW, Chang AC, Dreyer WJ, McMahon CJ, Grenier MA, Clunie SK, Thomas A, Moffett BS, Wann TS, Smith EO, Towbin JA.
    J Card Fail; 2007 Sep 23; 13(7):541-8. PubMed ID: 17826644
    [Abstract] [Full Text] [Related]

  • 7. Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients.
    Chow SL, Peng JT, Okamoto MP, Heywood JT.
    Ann Pharmacother; 2007 Apr 23; 41(4):556-61. PubMed ID: 17389662
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).
    van Deursen VM, Hernandez AF, Stebbins A, Hasselblad V, Ezekowitz JA, Califf RM, Gottlieb SS, O'Connor CM, Starling RC, Tang WH, McMurray JJ, Dickstein K, Voors AA.
    Circulation; 2014 Sep 16; 130(12):958-65. PubMed ID: 25074507
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.
    Yancy CW, Krum H, Massie BM, Silver MA, Stevenson LW, Cheng M, Kim SS, Evans R, FUSION II Investigators.
    Circ Heart Fail; 2008 May 16; 1(1):9-16. PubMed ID: 19808265
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
    Miller AH, Nazeer S, Pepe P, Estes B, Gorman A, Yancy CW.
    Ann Emerg Med; 2008 May 16; 51(5):571-8. PubMed ID: 18304693
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS, Stebbins A, Voors AA, Hasselblad V, Ezekowitz JA, Califf RM, O'Connor CM, Starling RC, Hernandez AF.
    J Am Coll Cardiol; 2013 Sep 24; 62(13):1177-83. PubMed ID: 23747790
    [Abstract] [Full Text] [Related]

  • 19. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
    Colucci WS, Elkayam U, Horton DP, Abraham WT, Bourge RC, Johnson AD, Wagoner LE, Givertz MM, Liang CS, Neibaur M, Haught WH, LeJemtel TH.
    N Engl J Med; 2000 Jul 27; 343(4):246-53. PubMed ID: 10911006
    [Abstract] [Full Text] [Related]

  • 20. Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure.
    Schwarz ER, Najam S, Akel R, Sulimanjee N, Bionat S, Rosanio S.
    J Cardiovasc Pharmacol Ther; 2007 Sep 27; 12(3):232-6. PubMed ID: 17875951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.